<table border="1" id="id_2dabb34c-89ec-464f-bba5-2607125591be" width="390" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 16. Mean Pharmacokinetic Parameters in Pediatric Patients With Epilepsy</caption>
<col span="1" width="32.6%"></col>
<col span="1" width="17.9%"></col>
<col span="1" width="13.8%"></col>
<col span="1" width="12.3%"></col>
<col span="1" width="23.3%"></col>
<tbody>
<tr>
<td> Pediatric Study Population </td>
<td> Number of Subjects </td>
<td> T<sub>max</sub> (hr) </td>
<td> t<sub>½</sub> (hr) </td>
<td> Cl/F (mL/min/kg) </td>
</tr>
<tr>
<td>
<content stylecode="bold">Ages 10 months to 5.3 years</content>
</td>
<td>   </td>
<td>   </td>
<td>   </td>
<td>   </td>
</tr>
<tr>
<td>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<linkhtml href="#footnote-11">*</linkhtml>
</td>
<td> 10 </td>
<td> 3 (1 to 5.9) </td>
<td> 7.7 (5.7 to 11.4) </td>
<td> 3.62 (2.44 to 5.28) </td>
</tr>
<tr>
<td>Patients taking AEDs with no known effect on the apparent clearance of lamotrigine </td>
<td> 7 </td>
<td> 5.2 (2.9 to 6.1) </td>
<td> 19 (12.9 to 27.1) </td>
<td> 1.2 (0.75 to 2.42) </td>
</tr>
<tr>
<td>Patients taking valproate only </td>
<td> 8 </td>
<td> 2.9 (1 to 6) </td>
<td> 44.9 (29.5 to 52.5) </td>
<td> 0.47 (0.23 to 0.77) </td>
</tr>
<tr>
<td>
<content stylecode="bold">Ages 5 to 11 years</content>
</td>
<td>   </td>
<td>   </td>
<td>   </td>
<td>   </td>
</tr>
<tr>
<td>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-37aaf910-f4a7-47d5-b911-ce2cc3bb7be8"></footnoteref>
</td>
<td> 7 </td>
<td> 1.6 (1 to 3) </td>
<td> 7 (3.8 to 9.8) </td>
<td> 2.54 (1.35 to 5.58) </td>
</tr>
<tr>
<td>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-37aaf910-f4a7-47d5-b911-ce2cc3bb7be8"></footnoteref> plus valproate </td>
<td> 8 </td>
<td> 3.3 (1 to 6.4) </td>
<td> 19.1 (7 to 31.2) </td>
<td> 0.89 (0.39 to 1.93) </td>
</tr>
<tr>
<td>Patients taking valproate only<linkhtml href="#footnote-12">†</linkhtml>
</td>
<td> 3 </td>
<td> 4.5 (3 to 6) </td>
<td> 65.8 (50.7 to 73.7) </td>
<td> 0.24 (0.21 to 0.26) </td>
</tr>
<tr>
<td>
<content stylecode="bold">Ages 13 to 18 years</content>
</td>
<td>   </td>
<td>   </td>
<td>   </td>
<td>   </td>
</tr>
<tr>
<td>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-37aaf910-f4a7-47d5-b911-ce2cc3bb7be8"></footnoteref>
</td>
<td> 11 </td>
<td>
<linkhtml href="#footnote-13">‡</linkhtml>
</td>
<td>
<footnoteref idref="id-84b75262-fb6f-4555-824c-86dc2c8ec67f"></footnoteref>
</td>
<td> 1.3 </td>
</tr>
<tr>
<td>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="id-37aaf910-f4a7-47d5-b911-ce2cc3bb7be8"></footnoteref> plus valproate </td>
<td> 8 </td>
<td>
<footnoteref idref="id-84b75262-fb6f-4555-824c-86dc2c8ec67f"></footnoteref>
</td>
<td>
<footnoteref idref="id-84b75262-fb6f-4555-824c-86dc2c8ec67f"></footnoteref>
</td>
<td> 0.5 </td>
</tr>
<tr>
<td>Patients taking valproate only </td>
<td> 4 </td>
<td>
<footnoteref idref="id-84b75262-fb6f-4555-824c-86dc2c8ec67f"></footnoteref>
</td>
<td>
<footnoteref idref="id-84b75262-fb6f-4555-824c-86dc2c8ec67f"></footnoteref>
</td>
<td> 0.3 </td>
</tr>
<tr>
<td>
<br/>
</td>
</tr>
</tbody>
</table>